NYU to develop ‘one-of-a-kind’ psychedelic medicine centre

Growth op

New York University (NYU) has announced the development a psychedelic medicine centre made possible by philanthropic support, including a US$5 million donation from MindMed. The NYU Langone Center for Psychedelic Medicine will support psychedelic research, ranging from basic science to clinical trials, and have three areas of focus: psychiatry, medicine and preclinical research. Forget taking a pill a day. Canada is using psychedelics to revolutionize the way we treat mental health and addiction Bruce Linton talks cannabis, psychedelics, and why he’s ‘unemployable’ Dispelling the negative reputation of medical cannabis In total, the university has received more than US$10 million in funding to establish the new facility. “These initiatives will provide an environment in which scientists, clinicians, trainees and other staff contribute in meaningful ways to ensure that the momentum created by the modern psychedelic renaissance is sustained and continues to yield medical breakthroughs backed by sound science,” says Dr. Michael Bogenschutz, who will serve as the centre’s director and is a professor of psychiatry at NYU Grossman School of Medicine. The centre will be the home of NYU’s Psychedelic Medicine Research Training Program, which launched last year to provide training for junior scientists interested in a career studying psychedelic and psychedelic-inspired treatments. Beyond psychiatry, research at the centre will investigate other potential health applications for psychedelic medicine. “Our broad focus on discovery for medical applications of psychedelics places NYU Langone at the vanguard of research on many difficult-to-treat psychiatric and medical disorders,” says Dr. Stephen Ross , an associate professor of psychiatry at NYU Grossman School of Medicine. “Moreover, we plan to utilize this health-focused structure to provide important training opportunities to sustain high-quality psychedelic research,” Dr. Ross adds. MindMed led a group of funders with a US$5 million donation. Backed by Bruce Linton and Kevin O’Leary , the MindMed…

Excerpt only …
Source : NYU to develop ‘one-of-a-kind’ psychedelic medicine centre

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.